Ewing's Sarcoma News and Research

RSS
The Ewing's family of tumors (EFT) includes primary tumors of bone (classic Ewing's sarcoma, primitive neuroectodermal tumor, and Askin tumor) and extraosseous primary tumors {National Cancer Institute}.
Initiatives to improve adolescent, young adult cancer outcomes justified

Initiatives to improve adolescent, young adult cancer outcomes justified

Two recently discovered compounds show promise for treating Ewing sarcoma in children

Two recently discovered compounds show promise for treating Ewing sarcoma in children

New screening technique to test drug compounds used in Ewing sarcoma treatment

New screening technique to test drug compounds used in Ewing sarcoma treatment

Role of genetic predisposition in pediatric cancer patients

Role of genetic predisposition in pediatric cancer patients

YK-4-279 compound works against some forms of leukemia: Study

YK-4-279 compound works against some forms of leukemia: Study

LMU researchers reveal role of mutations in development of Ewing's sarcoma

LMU researchers reveal role of mutations in development of Ewing's sarcoma

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

New therapeutic alternative found for children suffering from Ewing's sarcoma

New therapeutic alternative found for children suffering from Ewing's sarcoma

Phase II clinical trial of Linsitinib launched in patients with advanced Ewing sarcoma

Phase II clinical trial of Linsitinib launched in patients with advanced Ewing sarcoma

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

NanoSmart's ANA-conjugated liposomal doxorubicin receives FDA Orphan Drug Designation

Study could lead to potential therapeutic targets to treat Ewing Sarcoma

Study could lead to potential therapeutic targets to treat Ewing Sarcoma

Inhibition of SIRT1 protein may hold promise for treatment of metastatic Ewing sarcoma

Inhibition of SIRT1 protein may hold promise for treatment of metastatic Ewing sarcoma

Research findings may lead to new treatment strategies for Ewing sarcoma

Research findings may lead to new treatment strategies for Ewing sarcoma

Study identifies genetic alterations that contribute to growth and recurrence of Ewing sarcoma

Study identifies genetic alterations that contribute to growth and recurrence of Ewing sarcoma

Scientists reproduce chromosomal modifications in human cells that cause certain cancer

Scientists reproduce chromosomal modifications in human cells that cause certain cancer

Researchers reproduce tumor chromosomal translocations in human cells

Researchers reproduce tumor chromosomal translocations in human cells

Rosa/KressWorks Foundation completes first milestone in development of Ewing's sarcoma PhysioPD Platform

Rosa/KressWorks Foundation completes first milestone in development of Ewing's sarcoma PhysioPD Platform

Old FDA-approved drugs may hold promise for treatment of rare, drug-resistant cancer

Old FDA-approved drugs may hold promise for treatment of rare, drug-resistant cancer

Researchers suggest new targets may provide druggable alternatives to Ewing's Sarcoma

Researchers suggest new targets may provide druggable alternatives to Ewing's Sarcoma